Posted on 7/7/17
Celgene Endorsement Sees Beigene Come Of Age
Beigene (NASDAQ:BGNE), a group that has had a consistent if low-key presence at recent oncology conferences, looks finally to have come of age. In licensing its . . .
Posted on 7/7/17
Merck: Good Long-Term Despite Major Setback
On Wednesday, Merck (MRK) was notified by the FDA that it was hit with a clinical hold on three multiple myeloma studies that were treating patients . . .
Posted on 7/6/17
CytoSorbents Receives Additional $5 Million in Non-Dilutive Debt Financing from Bridge Bank
CytoSorbents Corporation (NASDAQ: CTSO), a leader in critical care immunotherapy specializing in blood purification, announced that on June 30, 2017 it received an additional $5 million . . .
Posted on 7/10/17
Celgene Corporation Enters Into Global Strategic Immuno-Oncology Collaboration with BeiGene
SUMMIT, N.J. & BEIJING--(BUSINESS WIRE)--Celgene Corporation (NASDAQ:CELG) and BeiGene, Ltd. (NASDAQ:BGNE) entered into a strategic collaboration to develop and commercialize BeiGene’s investigational anti-programmed cell death protein . . .
Posted on 7/6/17
Alexion Reaches Funding Agreement with NICE and NHS England
NEW HAVEN, Conn.--(BUSINESS WIRE)--Alexion Pharmaceuticals, Inc. (NASDAQ: ALXN) today announced that it has reached a national funding agreement with the National Institute for Health and Care . . .
Posted on 7/5/17
Johnson & Johnson Needs More Actelions
Johnson & Johnson (JNJ) has long been a company that has many cash demands. It pays a sizable dividend, buys back stock by the billion and . . .
Posted on 7/5/17
Interview - Johnson & Johnson Breathes New Life Into Infectious Diseases
When Johnson & Johnson (NYSE:JNJ) highlighted 12 potential blockbusters from its pipeline in May there were a few on the list that raised eyebrows. Two of . . .
Posted on 7/5/17
MTBC Acquires Regional Revenue Cycle Management Company
MTBC (NASDAQ: MTBC) (NASDAQ: MTBCP), a leading provider of proprietary, cloud-based healthcare IT solutions and services
Posted on 7/5/17
Better Buy: Pfizer Inc. vs. Eli Lilly and Company
Pfizer (NYSE:PFE) might be more than twice as big as fellow drugmaker Eli Lilly and Company (NYSE:LLY), but Lilly has been the better investment choice for . . .
Posted on 7/5/17
Better Buy: GlaxoSmithKline plc vs. Bristol-Myers Squibb
Big pharma stocks are arguably set to shine now that the threat of hard caps on drug prices is off the table. Global prescription drug sales, . . .
Posted on 7/5/17
Why Cara Therapeutics Stock Is Crashing
What happenedShares of Cara Therapeutics (NASDAQ:CARA), a clinical-stage biotech, dropped by as much as 28.1% in after-hours trading Thursday, and remain more than 25% lower in . . .
Posted on 7/5/17
PTC Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
PTC Therapeutics, Inc. (NASDAQ: PTCT) today announced that on June 27, 2017 it approved non-statutory stock options to purchase an aggregate of 74,750 shares of its . . .
Posted on 7/5/17
Spherix Closes Deal with Hoth Therapeutics
Spherix Incorporated (NASDAQ: SPEX) reported today, following the disclosure made June 20th 2017, that the Company has closed the transaction with Hoth Therapeutics. Hoth Therapeutics is . . .
Posted on 7/5/17
Ipsen Announces Dysport Co-Promotion Agreement with Saol Therapeutics
BASKING RIDGE, N.J.--(BUSINESS WIRE)--Ipsen Biopharmaceuticals, Inc., an affiliate of Ipsen SA (Euronext: IPN; ADR: IPSEY) (Ipsen), today announced that it has entered into an exclusive, three-year . . .
Posted on 6/29/17
Melinta Therapeutics Signs $90 Million Financing Agreement with Oberland Capital
New Haven, Conn, June 29, 2017 (GLOBE NEWSWIRE) -- Melinta Therapeutics, a privately held company developing novel antibiotics to treat serious bacterial infections, has entered into . . .
Posted on 6/29/17
5 Biotech Stocks With Major Catalysts in July
July brings fireworks and fun for many Americans. The month will also bring major catalysts for several biotechs. Those catalysts could provide a spark for the . . .
Posted on 6/28/17
Daniel Kubikian, DMD Named Top Dentist in Periodontics By Philadelphia Magazine, New Jersey Monthly and SJ Magazine
Daniel Kubikian DMD, Haddonfield resident and owner of South Jersey Periodontics and Dental Implants
Posted on 6/28/17
180 Degree Capital Corp.’s Portfolio Company, Mersana Therapeutics Completes IPO
MONTCLAIR, N.J., June 28, 2017 (GLOBE NEWSWIRE) -- 180 Degree Capital Corp. (NASDAQ:TURN) noted today that its portfolio company, Mersana Therapeutics, Inc., completed an initial public . . .
Posted on 6/28/17
2 Pharma Buyout Targets That May Surprise You
Mergers and acquisitions can be extremely profitable for pharmaceutical investors. A little over a year ago, for instance, Jazz Pharmaceuticals swooped in to buy Celator Pharmaceuticals . . .
Posted on 6/28/17
Applied DNA Sciences Signs New Licensing Agreement with Himatsingka America
STONY BROOK, N.Y.--(BUSINESS WIRE)--Applied DNA Sciences, Inc. is pleased to announce the signing of a new licensing agreement with Himatsingka America, Inc. (“Himatsingka”, “HAI”), which is . . .
Posted on 6/28/17
Jason Raines, DDS Named Top Dentist By New Jersey Monthly and South Jersey Magazine
Jason Raines DDS, owner of Raines Dental LLC in Mullica Hill, has been named one of the top dentists in the region by
Posted on 6/28/17
Dr. Luis Zapiach & Dr. John Cozzone Named "Top Doctors" in Plastic Surgery by Castle Connolly
From surgical procedures such breast augmentation and blepharoplasty to non-surgical treatments like Ultherapy® and dermal fillers, Dr. Luis Zapiach and Dr. John Cozzone strive to provide . . .
Posted on 6/27/17
Robin S. Plumer Joins Samaritan Healthcare & Hospice as Hospice and Palliative Care Physician
Robin S. Plumer, DO, of Cherry Hill, New Jersey, has joined Samaritan Healthcare & Hospice as a
Posted on 6/27/17
Pfizer: Negative Signs?
Pfizer Inc. (PFE) is a leading producer of pharmaceutical products. While the industry is believed to be on the rise, the company reported a decline in . . .
Posted on 6/26/17
AmeriHealth New Jersey Welcomes AtlantiCare to Tier 1 in Its AmeriHealth Advantage Suite of Products
CRANBURY, N.J.--(BUSINESS WIRE)--AmeriHealth New Jersey today announced that AtlantiCare will be a Tier 1 provider in its AmeriHealth Advantage suite of products effective July 1, 2017. . . .

